RE:RE:PIPERS JAFFRAYS CCI have been asking myself the same question.
If they show Blood Glucose level and Plasma Insulin level charts that look anything like the pre-clinical ones here: https://www.prometic.com/en/therapeutics/documents/ERA-EDTAposterPBI-4050TypeIIDiabetesLGFinal.pdf
then I think we are in for a good Tuesday.
I will also note the study outcomes listed here:
https://clinicaltrials.gov/ct2/show/NCT02562573?term=prometic&rank=3
I would expect read outs on all of these these.
- Change from baseline on waist circumference [ Time Frame: 9 months ] [ Designated as safety issue: No ]
- Change from baseline on biomarkers [ Time Frame: 9 months ] [ Designated as safety issue: No ]
% reduction and/or increase of biomarkers
- Change from baseline on antidiabetic treatment [ Time Frame: 9 months ] [ Designated as safety issue: No ]
Treatment discontinued, dosing change, and/or new medication added
- Change from baseline on triglycerides [ Time Frame: 9 months ] [ Designated as safety issue: No ]
- Change from baseline on BP [ Time Frame: 9 months ] [ Designated as safety issue: No ]
- Change from baseline on HDL-C [ Time Frame: 9 Months ] [ Designated as safety issue: No ]
- Change from baseline on fasting plasma glucose [ Time Frame: 9 months ] [ Designated as safety issue: No ]